The HIV epidemic persists in the U.S. largely because of racism -- and there's an insidiousness to that racism that can make it a challenge not only to pinpoint, but even to see in ourselves. Isolating examples of that unconscious bias doesn't directly solve the problem, but as today's lead study offers, it can make us more aware -- and help get us closer to devising solutions.
Here's what we've got on tap this week in our review of recently published, peer-reviewed, HIV-related research:
- Sexual behaviors are perceived as riskier for HIV or other sexually transmitted infections if one or more of the participants is black.
- The larger the constellation of psychosocial issues a young trans woman must work through, the higher the HIV risk becomes.
- A two-drug regimen of dolutegravir (Tivicay, DTG) and unboosted atazanavir (Reyataz) may be a viable switch option for some patients.
- Two case studies highlight that severe hepatotoxicity, even if rare, is still a risk worth being aware of when prescribing dolutegravir.
For a bit more on each of these findings, read onward. To beat HIV, you have to follow the science!